We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Cross-Linked Implants Reduce Revision Surgery Rates

By HospiMedica International staff writers
Posted on 13 Aug 2018
Print article
Image: The Procotyl Prime acetabular XLPE cup system (Photo courtesy of MicroPort Orthopedics).
Image: The Procotyl Prime acetabular XLPE cup system (Photo courtesy of MicroPort Orthopedics).
A long-term follow-up study confirms that hip implants made of cross-linked polyethylene (XLPE) substantially lower the risk of revision surgery after total hip replacement.

Researchers at the South Australian Health and Medical Research Institute (SAHMRI; Adelaide, Australia) and the University of Adelaide (UA; Australia) conducted an observational study of all patients who underwent THA for osteoarthritis (OA) in Australia from 1999 through December 31, 2016, in order to compare total hip arthroplasty (THA) revision surgery rates between patients that received XLPE implants and those that received conventional non-cross-linked polyethylene (CPE) at 16 years follow up.

The data, extracted from the Australian Orthopaedic Association (Sydney, Australia) national joint replacement registry, revealed that CPE was used in 41,171 procedures, and XLPE was used in 199,131; men and women who received XLPE implants were slightly younger than those that underwent CPE. XLPE implants were associated with a lower rate of revision at six months, with the difference becoming more apparent over time. The 16-year cumulative percentage of revisions of primary THAs was 11.7% in the CPE group and 6.2% in the XLPE group.

After adjustment for other risk factors, patients with CPE implants were about three times more likely to have revision surgery after nine years, compared to those with XLPE implants. At seven years, younger patients with CPE hip prostheses were about five times more likely to need revision surgery. Revisions directly related to wear of the bearing surface occurred in 0.81% of procedures that used CPE, compared to just 0.05% of procedures that used XLPE. The study was published on August 1, 2018, in The Journal of Bone & Joint Surgery.

“Wear-related and implant-longevity issues are particularly important in younger patients, who are generally more active and have a longer life span than their older counterparts,” concluded Professor Richard de Steiger, MD, of SAHMRI, and colleagues. “We believe that the evidence of reduced long-term wear with XLPE is now so strong that, when a polyethylene bearing surface is used in THA, it should be XLPE, particularly in younger patients."

THA is one of the most effective surgical procedures for the management of hip OA. The most common bearing surface for THA has been conventional CPE, which has been in use for over 50 years. As limiting wear of the bearing surface is critical to long-term success, particularly for younger patients, research has led to the development of XLPE, which has improved wear characteristics.

Related Links:
South Australian Health and Medical Research Institute
University of Adelaide
Australian Orthopaedic Association

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Hospital Bed Mattress Cover
Skin IQ 365
New
Wound Care Cart
UMGKA-3669-LTG

Print article

Channels

Critical Care

view channel
Image: The small but powerful invention could soon make life in the NICU easier for the tiniest patients (Photo courtesy of Georgia Institute of Technology)

Wireless Pacifier Monitors Vitals of NICU Babies Without Need for Painful Blood Draws

Newborns require frequent monitoring of their vital signs, with electrolyte levels being one of the most important indicators of their health. Currently, the only method to monitor these levels is through... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.